Frederik Faergemann Lau

Frederik Faergemann Lau

Auto-generated profile, based on publicly available information

Frederik Faergemann Lau

Department of Anesthesiology and Intensive Care Medicine Copenhagen University Hospital—Amager‐Hvidovre Copenhagen Denmark

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2022 in Clinical Epidemiology
Verified
Journal Article
Open access
PDF file
FLFrederik Faergemann Lau
Frederik Faergemann Lau
SBSigne Bollerup
Signe Bollerup
FEFrederik Engsig
Frederik Engsig
HKHenrik B. Bygum Krarup
Henrik B. Bygum Krarup
LMLone Hagens Mygind
Lone Hagens Mygind
Nina WeisNina Weis
Nina Weis
Objective: Data on the risk of ischemic heart disease (IHD) in patients with chronic hepatitis B virus (CHB) are conflicting. Our objective was to address the rate of IHD in patients with CHB compared with individuals without CHB (control-persons) from the general population. Study Design and Setting: We conducted a cohort study of prospectively obtained data from Danish nationwide registries. We produced cumulative incidence curves and calculated the unadjusted incidence rate ratio (IRR) of IHD in persons with and without CHB. The adjusted association between having CHB and developing IHD was examined using a cause-specific Cox regression model. Results: In total, 6472 persons with CHB and 62,251 age- and sex-matched individuals from the general population were followed for 48,840 and 567,456 person-years, respectively, during which 103 (1,59%) with CHB and 1058 (1,70%) control-persons developed IHD. The crude IRR was 1.13 (95% CI: 0.91– 1.39). CHB did not have a statistically significant effect on the rate of IHD after adjusting for several confounding factors (adjusted hazard ratio: 0.96, 95% CI: 0.76– 1.21). Conclusion: In this nationwide cohort study, we did not find any difference between rate of IHD in persons with CHB in comparison with the general population.

5 February 2025 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
FLFrederik F. Lau
Frederik F. Lau
NCNora Olsen El Caidi
Nora Olsen El Caidi
AHAna‐Marija Hristovska
Ana‐Marija Hristovska
MNMaryam Noory
Maryam Noory
JLJasmin Dam Lukoschewitz
Jasmin Dam Lukoschewitz
JGJohannes Grand
Johannes Grand

16 March 2026 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Open access
JGJohannes Grand
Johannes Grand
FLFrederik Færgemann Lau
Frederik Færgemann Lau
CHChristian Hassager
Christian Hassager
JBJohn Bro‐Jeppesen
John Bro‐Jeppesen
JMJacob Eifer Møller
Jacob Eifer Møller
JKJesper Kjærgaard
Jesper Kjærgaard
Introduction: Out‐of‐hospital cardiac arrest (OHCA) is associated with high mortality and substantial long‐term neurological sequelae among survivors. During postresuscitation intensive care after return of spontaneous circulation (ROSC), myocardial dysfunction, vasoplegia, and mixed shock states are often observed. Arterial blood pressure alone may not adequately reflect tissue perfusion or oxygen delivery. Advanced hemodynamic profiling has the potential to improve individualized postresuscitation management, but the overall evidence base has not been comprehensively mapped. Aims: This scoping review will map the available evidence on advanced hemodynamic monitoring during early postresuscitation care after adult OHCA (< 72 h after ROSC). Specifically, we will characterize which hemodynamic variables are measured, when and how they are measured, and in which clinical contexts; summarize how studies report associations between these variables and outcomes or markers of organ perfusion/function; and identify methodological gaps in hemodynamic monitoring. Methods: A scoping review will be conducted, including adult (≥ 18 years) patients hospitalized after OHCA with sustained ROSC. Eligible studies must investigate one or more predefined advanced hemodynamic parameters using invasive or non‐invasive techniques beyond arterial pressure monitoring. There are no restrictions on comparators, publication year, language, setting, or publication type. Animal, pediatric, simulation, intra‐arrest‐only studies, microcirculatory/local perfusion studies, and echocardiography‐only studies are excluded. MEDLINE (via PubMed) will be searched from inception to 31 January 2026. Two reviewers will screen and extract data independently in duplicate using Covidence. Data will be synthesized descriptively. Conclusions: This review will provide a comprehensive overview of advanced hemodynamic monitoring after OHCA and identify evidence and gaps in the research in this area.

23 July 2026 in Resuscitation
Verified
Journal Article
Open access
JGJohannes Grand
Johannes Grand
FLFrederik F. Lau
Frederik F. Lau
CHChristian Hassager
Christian Hassager
JBJohn Bro-Jeppesen
John Bro-Jeppesen
JMJacob Eifer Møller
Jacob Eifer Møller
JKJesper Kjærgaard
Jesper Kjærgaard

13 May 2026 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
FLFrederik F. Lau
Frederik F. Lau
SBSimon Brøkmann
Simon Brøkmann
MCMirjana Cihoric
Mirjana Cihoric
MLMorten Laksáfoss Lauritsen
Morten Laksáfoss Lauritsen
NFNicolai Bang Foss
Nicolai Bang Foss

28 August 2026 in Research and Practice in Thrombosis and Haemostasis
Verified
Journal Article
Open access
FLFrederik F. Lau
Frederik F. Lau
ESEmilie Sonne-Holm
Emilie Sonne-Holm
LBLia E. Bang
Lia E. Bang
JCJørn Carlsen
Jørn Carlsen
PUPeter Sommer Ulriksen
Peter Sommer Ulriksen
JKJesper Kjærgaard
Jesper Kjærgaard